Concepedia

Taihang Shao

TS

Statistics

Publications

4

Citations

94

H-Index

4

Active since

2022

Affiliations

China Pharmaceutical University(Current)

Taihang Shao is an author at China Pharmaceutical University specializing in cancer therapeutics, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2022–2024

4

Publications

4

Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

Taihang Shao, Mingye Zhao, Leyi Liang et al. · BioDrugs · 2023 · 37 citations

, , +9

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

Taihang Shao, Yinan Ren, Mingye Zhao et al. · Frontiers in Public Health · 2022 · 23 citations · Full text

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma

Taihang Shao, Mingye Zhao, Wenxi Tang · Frontiers in Oncology · 2022 · 21 citations · Full text

A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer

Hanqiao Shao, Mingye Zhao, Ai‐Jia Guan et al. · BMC Medicine · 2024 · 13 citations · Full text

Rows per page

1–4 of 4